Larvol Delta - Autobahn-Therapeutics-Advances-ABX002-its-Lead-Oral-Treatment-for-Major-Depressive-Disorder-into-MultiAscending-Dose-Portion-of-Phase-1-Trial

ABX-002 - Autobahn Therap

https://www.businesswire.com/news/home/20230418005389/en/Autobahn-Therapeutics-Advances-ABX-002-its-Lead-Oral-Treatment-for-Major-Depressive-Disorder-into-Multi-Ascending-Dose-Portion-of-Phase-1-Trial

Apr 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next